XML 57 R36.htm IDEA: XBRL DOCUMENT
v3.26.1

SEGMENT INFORMATION (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2026
Segment Reporting [Abstract] |
Schedule of Information about Reportable Segments and Reconciliation of Segment Operating Income and Pre-Tax Income | The table below presents information about Edwards Lifesciences' reportable segments (in millions):
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2026 |  | 2025 |  | 2026 |  | 2025
Segment Net Sales |  |  |  |  |  |  |
United States | $ | 1,003.5 |  |  | $ | 889.7 |  |  | $ | 1,941.1 |  |  | $ | 1,728.6 |
Europe | 439.6 |  |  | 378.2 |  |  | 882.2 |  |  | 720.0 |
Japan | 96.4 |  |  | 95.3 |  |  | 187.0 |  |  | 177.1 |
Rest of World | 201.5 |  |  | 169.0 |  |  | 379.3 |  |  | 319.2 |
Total segment net sales | $ | 1,741.0 |  |  | $ | 1,532.2 |  |  | $ | 3,389.6 |  |  | $ | 2,944.9 |
Cost of Sales |  |  |  |  |  |  |
United States | $ | 185.2 |  |  | $ | 167.5 |  |  | $ | 357.2 |  |  | $ | 313.5 |
Europe | 93.4 |  |  | 84.8 |  |  | 187.0 |  |  | 167.0 |
Japan | 15.3 |  |  | 13.6 |  |  | 29.6 |  |  | 25.9 |
Rest of World | 55.2 |  |  | 43.9 |  |  | 102.8 |  |  | 83.7 |
Total segment cost of sales | $ | 349.1 |  |  | $ | 309.8 |  |  | $ | 676.6 |  |  | $ | 590.1 |
Selling, general, and administrative expenses |  |  |  |  |  |  |
United States | $ | 164.7 |  |  | $ | 135.7 |  |  | $ | 318.8 |  |  | $ | 268.9 |
Europe | 76.3 |  |  | 74.2 |  |  | 148.1 |  |  | 147.6 |
Japan | 16.5 |  |  | 18.5 |  |  | 32.4 |  |  | 34.9 |
Rest of World | 50.0 |  |  | 48.3 |  |  | 98.0 |  |  | 90.4 |
Total segment selling, general, and administrative expenses | $ | 307.5 |  |  | $ | 276.7 |  |  | $ | 597.3 |  |  | $ | 541.8 |
Other Segment Items |  |  |  |  |  |  |
United States | $ | 0.7 |  |  | $ | 0.6 |  |  | $ | 1.5 |  |  | $ | 1.2 |
Europe | 38.1 |  |  | 15.2 |  |  | 80.0 |  |  | 6.9 |
Japan | (8.9) |  |  | (0.2) |  |  | (14.9) |  |  | (4.8) |
Rest of World | (7.1) |  |  | (7.9) |  |  | (14.6) |  |  | (17.1) |
Total other segment items (a) | $ | 22.8 |  |  | $ | 7.7 |  |  | $ | 52.0 |  |  | $ | (13.8) |
Segment Operating Income |  |  |  |  |  |  |
United States | $ | 652.9 |  |  | $ | 585.9 |  |  | $ | 1,263.6 |  |  | $ | 1,145.0 |
Europe | 231.8 |  |  | 204.0 |  |  | 467.1 |  |  | 398.5 |
Japan | 73.5 |  |  | 63.4 |  |  | 139.9 |  |  | 121.1 |
Rest of World | 103.4 |  |  | 84.7 |  |  | 193.1 |  |  | 162.2 |
Total segment operating income | $ | 1,061.6 |  |  | $ | 938.0 |  |  | $ | 2,063.7 |  |  | $ | 1,826.8 |
_______________________________________________________________________________ (a) Other segment items include research and development expenses and foreign currency. The table below presents a reconciliation of segment operating income to consolidated pre-tax income (in millions):
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2026 |  | 2025 |  | 2026 |  | 2025
Pre-tax Income Reconciliation |  |  |  |  |  |  |
Segment operating income | $ | 1,061.6 |  |  | $ | 938.0 |  |  | $ | 2,063.7 |  |  | $ | 1,826.8 |
Unallocated amounts: |  |  |  |  |  |  |
Corporate items | (538.3) |  |  | (505.2) |  |  | (1,033.1) |  |  | (991.4) |
Separation costs | — |  |  | (4.2) |  |  | — |  |  | (8.4) |
Certain litigation expenses | (6.3) |  |  | (15.5) |  |  | (43.4) |  |  | (26.4) |
Foreign currency | (3.8) |  |  | (1.9) |  |  | 3.6 |  |  | 5.4 |
Consolidated operating income | 513.2 |  |  | 411.2 |  |  | 990.8 |  |  | 806.0 |
Non-operating income (expense) | 6.6 |  |  | (11.0) |  |  | (12.0) |  |  | 28.1 |
Consolidated pre-tax income | $ | 519.8 |  |  | $ | 400.2 |  |  | $ | 978.8 |  |  | $ | 834.1 |
Schedule of Enterprise-Wide Information |
| Three Months Ended June 30, |  | Six Months Ended June 30,
| 2026 |  | 2025 |  | 2026 |  | 2025
Net Sales by Major Product Group |  |  |  |  |  |  |
Transcatheter Aortic Valve Replacement | $ | 1,258.3 |  |  | $ | 1,130.9 |  |  | $ | 2,455.6 |  |  | $ | 2,177.5 |
Transcatheter Mitral and Tricuspid Therapies | 198.6 |  |  | 134.5 |  |  | 373.7 |  |  | 249.7 |
Surgical | 284.1 |  |  | 266.8 |  |  | 560.3 |  |  | 517.7 |
| $ | 1,741.0 |  |  | $ | 1,532.2 |  |  | $ | 3,389.6 |  |  | $ | 2,944.9 |

X
- Definition Tabular disclosure of revenue attributed to and long-lived asset located in country of domicile and foreign country from which revenue is derived and in which asset is held, if it is not provided as part of reportable segment information. Long-lived asset excludes financial instrument, long-term customer relationship of financial institution, mortgage and other servicing rights, deferred policy acquisition cost, and deferred tax asset. Includes, but is not limited to, subtotal of geographical information about group of countries. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 + Details
Name: | us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of segment reporting. Includes, but is not limited to, reconciliation of reportable segment amount to corresponding consolidated total. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 34 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26C -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26A -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26A Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration